Menu
← Oncology Approval Tracker
FDA DECISION ·
Pemetrexed for Injection (Hospira)
pemetrexed · Hospira
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
An additional pemetrexed-for-injection product for labeled nonsquamous NSCLC uses and initial cisplatin combination treatment of unresectable or nonsurgical malignant pleural mesothelioma.
LAMPGEN ANALYSIS
Why it matters
The approval concerns an established antifolate supplied under a separate formulation application.
What research teams should watch
Check this product’s labeled partners, reconstitution and supplementation instructions before stocking.
PRIMARY RECORDS